|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q79665386
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235936.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q79665386
|
|
024
|
|
|
‡a
0000-0003-4767-7564
‡2
orcid
|
|
024
|
|
|
‡a
8527655300
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q79665386
|
|
100
|
0 |
|
‡a
Soon-Tae Lee
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Soon-Tae Lee
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A cell-free extract from human adipose stem cells protects mice against epilepsy
|
|
670
|
|
|
‡a
Author's A novel indicator, the "Jinx sign," is associated with an altered frontal-basal ganglionic connection
|
|
670
|
|
|
‡a
Author's Abnormal activation of motor cortical network during phasic REM sleep in idiopathic REM sleep behavior disorder
|
|
670
|
|
|
‡a
Author's Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration
|
|
670
|
|
|
‡a
Author's Acute Symptomatic Basilar Artery Stenosis: MR Imaging Predictors of Early Neurologic Deterioration and Long-term Outcomes
|
|
670
|
|
|
‡a
Author's Altered behavior and neural activity in conspecific cagemates co-housed with mouse models of brain disorders
|
|
670
|
|
|
‡a
Author's Altered expression of miR-202 in cerebellum of multiple-system atrophy
|
|
670
|
|
|
‡a
Author's Altered Expression of the Long Noncoding RNA NEAT1 in Huntington's Disease.
|
|
670
|
|
|
‡a
Author's Altered Functional Connectivity in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Resting-State EEG Study
|
|
670
|
|
|
‡a
Author's Altered long noncoding RNA profile after intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Altered microRNA regulation in Huntington's disease models
|
|
670
|
|
|
‡a
Author's Altered Network Characteristics of Spike-Wave Discharges in Juvenile Myoclonic Epilepsy.
|
|
670
|
|
|
‡a
Author's Altered resting-state thalamo-occipital functional connectivity is associated with cognition in isolated rapid eye movement sleep behavior disorder
|
|
670
|
|
|
‡a
Author's An illustrative case of mixed pesticide poisoning with remarkable improvement: a case report
|
|
670
|
|
|
‡a
Author's Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke
|
|
670
|
|
|
‡a
Author's Anti-LGI1 encephalitis is associated with unique HLA subtypes.
|
|
670
|
|
|
‡a
Author's Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
|
|
670
|
|
|
‡a
Author's Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome
|
|
670
|
|
|
‡a
Author's Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy
|
|
670
|
|
|
‡a
Author's Association of blood pressure variability with orthostatic intolerance symptoms.
|
|
670
|
|
|
‡a
Author's Association of Bone Mineral Density With the Risk of Intracranial Aneurysm
|
|
670
|
|
|
‡a
Author's Association of Cardiac Hemodynamic Factors With Severity of White Matter Hyperintensities in Chronic Valvular Heart Disease
|
|
670
|
|
|
‡a
Author's Atherosclerosis-Related Circulating MicroRNAs as a Predictor of Stroke Recurrence
|
|
670
|
|
|
‡a
Author's Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways
|
|
670
|
|
|
‡a
Author's Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition
|
|
670
|
|
|
‡a
Author's Autophagy is involved in the ischemic preconditioning
|
|
670
|
|
|
‡a
Author's Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.
|
|
670
|
|
|
‡a
Author's Brain response characteristics associated with subclavian steal phenomenon.
|
|
670
|
|
|
‡a
Author's Brainstem encephalitis caused by Coxiella burnetii
|
|
670
|
|
|
‡a
Author's Bright light exposure before bedtime impairs response inhibition the following morning: a non-randomized crossover study.
|
|
670
|
|
|
‡a
Author's c-Cbl regulates αPix-mediated cell migration and invasion.
|
|
670
|
|
|
‡a
Author's Ca<sub>V</sub> α2δ Autoimmune Encephalitis: A Novel Antibody and its Characteristics
|
|
670
|
|
|
‡a
Author's Campylobacter fetus meningitis confirmed by a 16S rRNA gene analysis using the MinION nanopore sequencer, South Korea, 2016.
|
|
670
|
|
|
‡a
Author's Capability of arterial spin labeling MR imaging in localizing seizure focus in clinical seizure activity
|
|
670
|
|
|
‡a
Author's Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis
|
|
670
|
|
|
‡a
Author's Case of Rickettsia typhi-induced Brain Abscess Mimicking Brain Tumor.
|
|
670
|
|
|
‡a
Author's Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death
|
|
670
|
|
|
‡a
Author's Cell proliferation and synaptogenesis in the cerebellum after focal cerebral ischemia.
|
|
670
|
|
|
‡a
Author's Central nervous system complications after liver transplantation.
|
|
670
|
|
|
‡a
Author's Central Nervous System Infection Associated with Orientia tsutsugamushi in South Korea.
|
|
670
|
|
|
‡a
Author's Cerebral autoinflammatory disease treated with anakinra.
|
|
670
|
|
|
‡a
Author's Change of Patient Selection Strategy and Improved Surgical Outcome in MRI-negative Neocortical Epilepsy
|
|
670
|
|
|
‡a
Author's Characteristics of Epilepsy Patients who Committed Violent Crimes: Report from the National Forensic Hospital
|
|
670
|
|
|
‡a
Author's Cholinergic anti-inflammatory pathway in intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Circulating CD62E+ microparticles and cardiovascular outcomes
|
|
670
|
|
|
‡a
Author's Circulating endothelial microparticles as a marker of cerebrovascular disease.
|
|
670
|
|
|
‡a
Author's Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke
|
|
670
|
|
|
‡a
Author's Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease
|
|
670
|
|
|
‡a
Author's Clinical and angiographic factors related to the prognosis of cavernous sinus dural arteriovenous fistula
|
|
670
|
|
|
‡a
Author's Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy.
|
|
670
|
|
|
‡a
Author's Clinical Approach to Autoimmune Epilepsy
|
|
670
|
|
|
‡a
Author's Clinical Characteristics of Severe Japanese Encephalitis: A Case Series from South Korea.
|
|
670
|
|
|
‡a
Author's Clinical characterization of unknown/cryptogenic status epilepticus suspected as encephalitis: A multicenter cohort study.
|
|
670
|
|
|
‡a
Author's Clinical manifestation of cancer related stroke: retrospective case-control study
|
|
670
|
|
|
‡a
Author's Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis
|
|
670
|
|
|
‡a
Author's Clinical manifestations and treatment outcomes of parvovirus B19 encephalitis in immunocompetent adults.
|
|
670
|
|
|
‡a
Author's Clinical manifestations of patients with CASPR2 antibodies.
|
|
670
|
|
|
‡a
Author's Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma
|
|
670
|
|
|
‡a
Author's Clustering of spontaneous recurrent seizures separated by long seizure-free periods: An extended video-EEG monitoring study of a pilocarpine mouse model.
|
|
670
|
|
|
‡a
Author's Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia
|
|
670
|
|
|
‡a
Author's Comorbid Depression Is Associated with a Negative Treatment Response in Idiopathic REM Sleep Behavior Disorder
|
|
670
|
|
|
‡a
Author's Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas
|
|
670
|
|
|
‡a
Author's Continuous cytosine-b-D-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
|
|
670
|
|
|
‡a
Author's Correction: Clustering of spontaneous recurrent seizures separated by long seizure-free periods: An extended video-EEG monitoring study of a pilocarpine mouse model
|
|
670
|
|
|
‡a
Author's Correction: Direct Generation of Neurosphere-Like Cells from Human Dermal Fibroblasts
|
|
670
|
|
|
‡a
Author's Corrigendum to "Altered resting-state thalamo-occipital functional connectivity is associated with cognition in isolated rapid eye movement sleep behavior disorder" [Sleep Med 69 (2020) 198-203]
|
|
670
|
|
|
‡a
Author's Criminal manifestations of dementia patients: report from the national forensic hospital
|
|
670
|
|
|
‡a
Author's Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
|
|
670
|
|
|
‡a
Author's Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression.
|
|
670
|
|
|
‡a
Author's Delayed orthostatic hypotension: Severity of clinical symptoms and response to medical treatment
|
|
670
|
|
|
‡a
Author's Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.
|
|
670
|
|
|
‡a
Author's Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies
|
|
670
|
|
|
‡a
Author's Development of LGI1 antibody encephalitis after treatment of lung cancer
|
|
670
|
|
|
‡a
Author's Development of the clinical assessment scale in autoimmune encephalitis
|
|
670
|
|
|
‡a
Author's Diagnosis of Haemophilus influenzae Pneumonia by Nanopore 16S Amplicon Sequencing of Sputum
|
|
670
|
|
|
‡a
Author's Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
|
|
670
|
|
|
‡a
Author's Direct generation of neurosphere-like cells from human dermal fibroblasts
|
|
670
|
|
|
‡a
Author's Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
|
|
670
|
|
|
‡a
Author's Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
|
|
670
|
|
|
‡a
Author's Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.
|
|
670
|
|
|
‡a
Author's Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value
|
|
670
|
|
|
‡a
Author's Dysfunctional characteristics of circulating angiogenic cells in Alzheimer's disease.
|
|
670
|
|
|
‡a
Author's Dysregulated long non-coding RNAs in the temporal lobe epilepsy mouse model.
|
|
670
|
|
|
‡a
Author's Dysregulation of long non-coding RNAs in mouse models of localization-related epilepsy.
|
|
670
|
|
|
‡a
Author's Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level.
|
|
670
|
|
|
‡a
Author's Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury
|
|
670
|
|
|
‡a
Author's Echocardiographic evidence of innate aortopathy in the human intracranial aneurysm
|
|
670
|
|
|
‡a
Author's Echocardiographic index E/e' in association with cerebral white matter hyperintensity progression
|
|
670
|
|
|
‡a
Author's Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study
|
|
670
|
|
|
‡a
Author's Effects of long term nitrite therapy on functional recovery in experimental ischemia model.
|
|
670
|
|
|
‡a
Author's Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
|
|
670
|
|
|
‡a
Author's Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
|
|
670
|
|
|
‡a
Author's Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension
|
|
670
|
|
|
‡a
Author's Erratum to: Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.
|
|
670
|
|
|
‡a
Author's Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models
|
|
670
|
|
|
‡a
Author's Erythropoietin reduces epileptogenic processes following status epilepticus
|
|
670
|
|
|
‡a
Author's Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Etiology and prognosis of non-convulsive status epilepticus
|
|
670
|
|
|
‡a
Author's Exosome-Based Delivery of miR-124 in a Huntington's Disease Model
|
|
670
|
|
|
‡a
Author's Experimental Induction of Cerebral Aneurysms by Developmental Low Copper Diet
|
|
670
|
|
|
‡a
Author's Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's disease
|
|
670
|
|
|
‡a
Author's Fatal familial insomnia presenting with agrypnia excitata and very low atonia index level: A case report and literature review
|
|
670
|
|
|
‡a
Author's Feasibility and Safety of Intra-arterial Pericyte Progenitor Cell Delivery Following Mannitol-Induced Transient Blood-Brain Barrier Opening in a Canine Model
|
|
670
|
|
|
‡a
Author's Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia
|
|
670
|
|
|
‡a
Author's Frequent rhabdomyolysis in anti-NMDA receptor encephalitis
|
|
670
|
|
|
‡a
Author's G-CSF protects human cerebral hybrid neurons against in vitro ischemia
|
|
670
|
|
|
‡a
Author's Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
|
|
670
|
|
|
‡a
Author's Gamma oscillation in functional brain networks is involved in the spontaneous remission of depressive behavior induced by chronic restraint stress in mice
|
|
670
|
|
|
‡a
Author's Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease
|
|
670
|
|
|
‡a
Author's Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia
|
|
670
|
|
|
‡a
Author's Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation
|
|
670
|
|
|
‡a
Author's Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease.
|
|
670
|
|
|
‡a
Author's High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
|
|
670
|
|
|
‡a
Author's High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy
|
|
670
|
|
|
‡a
Author's High-Fat Diet and Voluntary Chronic Aerobic Exercise Recover Altered Levels of Aging-Related Tryptophan Metabolites along the Kynurenine Pathway
|
|
670
|
|
|
‡a
Author's HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events
|
|
670
|
|
|
‡a
Author's HLA-A*31:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population
|
|
670
|
|
|
‡a
Author's HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption
|
|
670
|
|
|
‡a
Author's HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor
|
|
670
|
|
|
‡a
Author's HLAs associated with perampanel-induced psychiatric adverse effects in a Korean population
|
|
670
|
|
|
‡a
Author's HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions
|
|
670
|
|
|
‡a
Author's Human leukocyte antigen associations in postural tachycardia syndrome
|
|
670
|
|
|
‡a
Author's Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats
|
|
670
|
|
|
‡a
Author's Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia
|
|
670
|
|
|
‡a
Author's Ictal asystole and eating reflex seizures with temporal lobe epilepsy.
|
|
670
|
|
|
‡a
Author's Identification of cerebral perfusion using arterial spin labeling in patients with seizures in acute settings
|
|
670
|
|
|
‡a
Author's Identification of neuronal outgrowth cells from peripheral blood of stroke patients.
|
|
670
|
|
|
‡a
Author's Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study
|
|
670
|
|
|
‡a
Author's Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy.
|
|
670
|
|
|
‡a
Author's Impact of stroke mechanism in acute basilar occlusion with reperfusion therapy.
|
|
670
|
|
|
‡a
Author's Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with korean red ginseng
|
|
670
|
|
|
‡a
Author's Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis
|
|
670
|
|
|
‡a
Author's Increased arterial pulsatility and progression of single subcortical infarction.
|
|
670
|
|
|
‡a
Author's Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea.
|
|
670
|
|
|
‡a
Author's Increasing prevalence of antimicrobial resistance in urinary tract infections of neurological patients, Seoul, South Korea, 2007-2016
|
|
670
|
|
|
‡a
Author's Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus
|
|
670
|
|
|
‡a
Author's Inhibition of Let7c microRNA is neuroprotective in a rat intracerebral hemorrhage model
|
|
670
|
|
|
‡a
Author's Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice
|
|
670
|
|
|
‡a
Author's Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
|
|
670
|
|
|
‡a
Author's Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model
|
|
670
|
|
|
‡a
Author's Isolated and prolonged loss of time orientation
|
|
670
|
|
|
‡a
Author's Let-7 microRNA inhibits the proliferation of human glioblastoma cells
|
|
670
|
|
|
‡a
Author's LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
|
|
670
|
|
|
‡a
Author's Light-induced amaurosis fugax due to severe distal internal carotid artery stenosis: in view of managing ocular ischemic syndrome.
|
|
670
|
|
|
‡a
Author's Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.
|
|
670
|
|
|
‡a
Author's Maternal immune activation alters brain microRNA expression in mouse offspring
|
|
670
|
|
|
‡a
Author's Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy
|
|
670
|
|
|
‡a
Author's Mega-dose phenobarbital therapy for super-refractory status epilepticus
|
|
670
|
|
|
‡a
Author's Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement
|
|
670
|
|
|
‡a
Author's Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease
|
|
670
|
|
|
‡a
Author's MicroRNAs induced during ischemic preconditioning
|
|
670
|
|
|
‡a
Author's miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model
|
|
670
|
|
|
‡a
Author's Modulation of mitochondrial function by stem cell-derived cellular components.
|
|
670
|
|
|
‡a
Author's MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes
|
|
670
|
|
|
‡a
Author's Molecular alterations underlying epileptogenesis after prolonged febrile seizure and modulation by erythropoietin.
|
|
670
|
|
|
‡a
Author's MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction
|
|
670
|
|
|
‡a
Author's Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model
|
|
670
|
|
|
‡a
Author's Multipotent PDGFRβ-expressing cells in the circulation of stroke patients
|
|
670
|
|
|
‡a
Author's Neuro-Behcet's disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review
|
|
670
|
|
|
‡a
Author's Neuropathologic and clinical features of human medial temporal lobe epilepsy.
|
|
670
|
|
|
‡a
Author's Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models
|
|
670
|
|
|
‡a
Author's Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington's disease
|
|
670
|
|
|
‡a
Author's Neurotoxic syndrome developed after taking sertraline and risperidone
|
|
670
|
|
|
‡a
Author's Neurovascular Cell Sheet Transplantation in a Canine Model of Intracranial Hemorrhage
|
|
670
|
|
|
‡a
Author's New Concept of Neural Stem Cell Transplantation: Anti-inflammatory Role.
|
|
670
|
|
|
‡a
Author's New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2.
|
|
670
|
|
|
‡a
Author's Non-stiff anti-amphiphysin syndrome: clinical manifestations and outcome after immunotherapy
|
|
670
|
|
|
‡a
Author's Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease
|
|
670
|
|
|
‡a
Author's Novel mutation in the ATL1 with autosomal dominant hereditary spastic paraplegia presented as dysautonomia.
|
|
670
|
|
|
‡a
Author's Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status
|
|
670
|
|
|
‡a
Author's NREM Sleep EEG Oscillations in Idiopathic REM Sleep Behavior Disorder: A study of sleep spindles and slow oscillations
|
|
670
|
|
|
‡a
Author's Nuclear localization of huntingtin during spermatogenesis
|
|
670
|
|
|
‡a
Author's Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome
|
|
670
|
|
|
‡a
Author's Panax ginseng enhances cognitive performance in Alzheimer disease.
|
|
670
|
|
|
‡a
Author's Paradoxical Choroid Plexitis during Treatment for Tuberculous Meningoencephalitis
|
|
670
|
|
|
‡a
Author's Periodicity of cerebral flow velocity during sleep and its association with white-matter hyperintensity volume
|
|
670
|
|
|
‡a
Author's Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
|
|
670
|
|
|
‡a
Author's Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage
|
|
670
|
|
|
‡a
Author's Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1
|
|
670
|
|
|
‡a
Author's Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation
|
|
670
|
|
|
‡a
Author's Pharmacological Treatment of Epilepsy in Elderly Patients
|
|
670
|
|
|
‡a
Author's Pneumonia in hospitalized neurologic patients: trends in pathogen distribution and antibiotic susceptibility
|
|
670
|
|
|
‡a
Author's Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy
|
|
670
|
|
|
‡a
Author's Possible epigenetic regulatory effect of dysregulated circular RNAs in Alzheimer's disease model
|
|
670
|
|
|
‡a
Author's Possible epigenetic regulatory effect of dysregulated circular RNAs in epilepsy
|
|
670
|
|
|
‡a
Author's Predictors of survival for patients with cancer after cryptogenic stroke
|
|
670
|
|
|
‡a
Author's Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in Korea.
|
|
670
|
|
|
‡a
Author's Profiles of multidrug resistance protein-1 in the peripheral blood mononuclear cells of patients with refractory epilepsy
|
|
670
|
|
|
‡a
Author's Prognosis of spontaneous cervical artery dissection and transcranial Doppler findings associated with clinical outcomes
|
|
670
|
|
|
‡a
Author's Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
|
|
670
|
|
|
‡a
Author's Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions
|
|
670
|
|
|
‡a
Author's Prognostic Value of Initial Standard EEG and MRI in Patients with Herpes Simplex Encephalitis
|
|
670
|
|
|
‡a
Author's Progression of Cerebral White Matter Hyperintensities and the Associated Sonographic Index
|
|
670
|
|
|
‡a
Author's Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder
|
|
670
|
|
|
‡a
Author's Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib
|
|
670
|
|
|
‡a
Author's Psychiatric symptoms delay the diagnosis of anti-LGI1 encephalitis.
|
|
670
|
|
|
‡a
Author's Quantification of human neural stem cell engraftments in rat brains using ERV-3 real-time PCR.
|
|
670
|
|
|
‡a
Author's Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.
|
|
670
|
|
|
‡a
Author's Rapid diagnosis of bacterial meningitis by nanopore 16S amplicon sequencing: A pilot study
|
|
670
|
|
|
‡a
Author's Reduced P300 amplitude during a visuospatial attention task in idiopathic rapid eye movement sleep behavior disorder.
|
|
670
|
|
|
‡a
Author's Reemergence of Japanese Encephalitis in South Korea, 2010–2015
|
|
670
|
|
|
‡a
Author's Refining General Principles of Antiepileptic Drug Treatments for Epilepsy
|
|
670
|
|
|
‡a
Author's Region-specific plasticity in the epileptic rat brain: a hippocampal and extrahippocampal analysis
|
|
670
|
|
|
‡a
Author's Reply to "Grading the severity of autoimmune encephalitis: Advances and pitfalls"
|
|
670
|
|
|
‡a
Author's Reply to "Grading the Severity of Autoimmune Encephalitis: When to Evaluate?"
|
|
670
|
|
|
‡a
Author's Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effects in a Mouse Model of Depression
|
|
670
|
|
|
‡a
Author's Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles
|
|
670
|
|
|
‡a
Author's Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
|
|
670
|
|
|
‡a
Author's Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis
|
|
670
|
|
|
‡a
Author's Role of cortical dysplasia in epileptogenesis following prolonged febrile seizure
|
|
670
|
|
|
‡a
Author's Safety of tianeptine use in patients with epilepsy
|
|
670
|
|
|
‡a
Author's Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs
|
|
670
|
|
|
‡a
Author's Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes
|
|
670
|
|
|
‡a
Author's Site-Specific Relationship Between Intracranial Aneurysm and Aortic Aneurysm
|
|
670
|
|
|
‡a
Author's Slowed progression in models of Huntington disease by adipose stem cell transplantation
|
|
670
|
|
|
‡a
Author's Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation.
|
|
670
|
|
|
‡a
Author's Sonographic findings associated with stenosis progression and vascular complications in moyamoya disease.
|
|
670
|
|
|
‡a
Author's Stem cell-based cell therapy for Huntington disease: a review
|
|
670
|
|
|
‡a
Author's Stem Cells Transplantation and Huntington's Disease
|
|
670
|
|
|
‡a
Author's Stroke mimicking encephalopathy as an initial manifestation of diffuse large B-cell lymphoma
|
|
670
|
|
|
‡a
Author's Successful Treatment of Refractory Dyskinesia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Electroconvulsive Therapy
|
|
670
|
|
|
‡a
Author's Sun ginseng protects endothelial progenitor cells from senescence associated apoptosis
|
|
670
|
|
|
‡a
Author's Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups
|
|
670
|
|
|
‡a
Author's Switching between phenytoin generics in patients with epilepsy may lead to increased risk of breakthrough seizure: chart analysis and practice recommendations
|
|
670
|
|
|
‡a
Author's Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model.
|
|
670
|
|
|
‡a
Author's The c-Abl inhibitor, nilotinib, as a potential therapeutic agent for chronic cerebellar ataxia
|
|
670
|
|
|
‡a
Author's The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability.
|
|
670
|
|
|
‡a
Author's The effect of dim light at night on cerebral hemodynamic oscillations during sleep: A near-infrared spectroscopy study
|
|
670
|
|
|
‡a
Author's The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect
|
|
670
|
|
|
‡a
Author's The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy
|
|
670
|
|
|
‡a
Author's The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population
|
|
670
|
|
|
‡a
Author's The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre
|
|
670
|
|
|
‡a
Author's Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study
|
|
670
|
|
|
‡a
Author's Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study.
|
|
670
|
|
|
‡a
Author's Tocilizumab treatment for new-onset refractory status epilepticus
|
|
670
|
|
|
‡a
Author's Tolerability of lacosamide rapid dose titration: A randomized, multicenter, prospective, open-label study
|
|
670
|
|
|
‡a
Author's Tolerated nitrite therapy in experimental intracerebral hemorrhage: Rationale of nitrite therapy in a broad range of hyperacute strokes.
|
|
670
|
|
|
‡a
Author's Topiramate increases the risk of valproic acid-induced encephalopathy
|
|
670
|
|
|
‡a
Author's Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1 Alpha stabilization in the host brain
|
|
670
|
|
|
‡a
Author's Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice
|
|
670
|
|
|
‡a
Author's Treatment strategies for autoimmune encephalitis
|
|
670
|
|
|
‡a
Author's Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma
|
|
670
|
|
|
‡a
Author's Unfavorable surgical outcomes in partial epilepsy with secondary bilateral synchrony: Intracranial electroencephalography study.
|
|
670
|
|
|
‡a
Author's Unique behavioral characteristics and microRNA signatures in a drug resistant epilepsy model
|
|
670
|
|
|
‡a
Author's Usefulness of saliva for perampanel therapeutic drug monitoring
|
|
670
|
|
|
‡a
Author's Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
|
|
670
|
|
|
‡a
Author's VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.
|
|
670
|
|
|
‡a
Author's White matter hyperintensities and cognitive dysfunction in Alzheimer disease
|
|
909
|
|
|
‡a
(scopus) 8527655300
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000347677564
‡9
1
|
|
919
|
|
|
‡a
antiinflammatorymechanismofintravascularneuralstemcelltransplantationinhaemorrhagicstroke
‡A
Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke
‡9
1
|
|
919
|
|
|
‡a
alterednetworkcharacteristicsofspikewavedischargesinjuvenilemyoclonicepilepsy
‡A
Altered Network Characteristics of Spike-Wave Discharges in Juvenile Myoclonic Epilepsy.
‡9
1
|
|
919
|
|
|
‡a
alteredmicrornaregulationinhuntingtonsdiseasemodels
‡A
Altered microRNA regulation in Huntington's disease models
‡9
1
|
|
919
|
|
|
‡a
alteredlongnoncodingrnaprofileafterintracerebralhemorrhage
‡A
Altered long noncoding RNA profile after intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
alteredfunctionalconnectivityinidiopathicrapideyemovementsleepbehaviordisorderarestingstateeegstudy
‡A
Altered Functional Connectivity in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Resting-State EEG Study
‡9
1
|
|
919
|
|
|
‡a
alteredexpressionofthelongnoncodingrnaneat1inhuntingtonsdisease
‡A
Altered Expression of the Long Noncoding RNA NEAT1 in Huntington's Disease.
‡9
1
|
|
919
|
|
|
‡a
alteredexpressionofmir202incerebellumofmultiplesystematrophy
‡A
Altered expression of miR-202 in cerebellum of multiple-system atrophy
‡9
1
|
|
919
|
|
|
‡a
alteredbehaviorandneuralactivityinconspecificcagematescohousedwithmousemodelsofbraindisorders
‡A
Altered behavior and neural activity in conspecific cagemates co-housed with mouse models of brain disorders
‡9
1
|
|
919
|
|
|
‡a
acutesymptomaticbasilararterystenosismrimagingpredictorsofearlyneurologicdeteriorationandlongtermoutcomes
‡A
Acute Symptomatic Basilar Artery Stenosis: MR Imaging Predictors of Early Neurologic Deterioration and Long-term Outcomes
‡9
1
|
|
919
|
|
|
‡a
acquiredencephalopathyassociatedwithcarnitinedeficiencyaftercefditorenpivoxiladministration
‡A
Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration
‡9
1
|
|
919
|
|
|
‡a
abnormalactivationofmotorcorticalnetworkduringphasicremsleepinidiopathicremsleepbehaviordisorder
‡A
Abnormal activation of motor cortical network during phasic REM sleep in idiopathic REM sleep behavior disorder
‡9
1
|
|
919
|
|
|
‡a
novelindicatorthejinxsignisassociatedwithanalteredfrontalbasalganglionicconnection
‡A
A novel indicator, the "Jinx sign," is associated with an altered frontal-basal ganglionic connection
‡9
1
|
|
919
|
|
|
‡a
cellfreeextractfromhumanadiposestemcellsprotectsmiceagainstepilepsy
‡A
A cell-free extract from human adipose stem cells protects mice against epilepsy
‡9
1
|
|
919
|
|
|
‡a
antilgi1encephalitisisassociatedwithuniquehlasubtypes
‡A
Anti-LGI1 encephalitis is associated with unique HLA subtypes.
‡9
1
|
|
919
|
|
|
‡a
antilgi1limbicencephalitispresentedwithatypicalmanifestations
‡A
Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
‡9
1
|
|
919
|
|
|
‡a
antinmethyl500aspartatereceptorencephalitisinkoreaclinicalfeaturestreatmentandoutcome
‡A
Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome
‡9
1
|
|
919
|
|
|
‡a
antiepilepticdrugselectionaccordingtoseizuretypeinadultpatientswithepilepsy
‡A
Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy
‡9
1
|
|
919
|
|
|
‡a
associationofbloodpressurevariabilitywithorthostaticintolerancesymptoms
‡A
Association of blood pressure variability with orthostatic intolerance symptoms.
‡9
1
|
|
919
|
|
|
‡a
associationofbonemineraldensitywiththeriskofintracranialaneurysm
‡A
Association of Bone Mineral Density With the Risk of Intracranial Aneurysm
‡9
1
|
|
919
|
|
|
‡a
associationofcardiachemodynamicfactorswithseverityofwhitematterhyperintensitiesinchronicvalvularheartdisease
‡A
Association of Cardiac Hemodynamic Factors With Severity of White Matter Hyperintensities in Chronic Valvular Heart Disease
‡9
1
|
|
919
|
|
|
‡a
atherosclerosisrelatedcirculatingmicrornasasapredictorofstrokerecurrence
‡A
Atherosclerosis-Related Circulating MicroRNAs as a Predictor of Stroke Recurrence
‡9
1
|
|
919
|
|
|
‡a
atorvastatinattenuatesmitochondrialtoxininducedstriataldegenerationwithdecreasinginos100junlevelsandactivatingerkaktpathways
‡A
Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways
‡9
1
|
|
919
|
|
|
‡a
augmentationofnitritetherapyincerebralischemiabynmdareceptorinhibition
‡A
Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition
‡9
1
|
|
919
|
|
|
‡a
autophagyisinvolvedintheischemicpreconditioning
‡A
Autophagy is involved in the ischemic preconditioning
‡9
1
|
|
919
|
|
|
‡a
blockadeofat1receptorreducesapoptosisinflammationandoxidativestressinnormotensiveratswithintracerebralhemorrhage
‡A
Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
bortezomibtreatmentforsevererefractoryantinmdareceptorencephalitis
‡A
Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.
‡9
1
|
|
919
|
|
|
‡a
brainresponsecharacteristicsassociatedwithsubclavianstealphenomenon
‡A
Brain response characteristics associated with subclavian steal phenomenon.
‡9
1
|
|
919
|
|
|
‡a
brainstemencephalitiscausedbycoxiellaburnetii
‡A
Brainstem encephalitis caused by Coxiella burnetii
‡9
1
|
|
919
|
|
|
‡a
brightlightexposurebeforebedtimeimpairsresponseinhibitionthefollowingmorninganonrandomizedcrossoverstudy
‡A
Bright light exposure before bedtime impairs response inhibition the following morning: a non-randomized crossover study.
‡9
1
|
|
919
|
|
|
‡a
100cblregulatesαpixmediatedcellmigrationandinvasion
‡A
c-Cbl regulates αPix-mediated cell migration and invasion.
‡9
1
|
|
919
|
|
|
‡a
casub5subα2δautoimmuneencephalitisanovelantibodyanditscharacteristics
‡A
Ca<sub>V</sub> α2δ Autoimmune Encephalitis: A Novel Antibody and its Characteristics
‡9
1
|
|
919
|
|
|
‡a
campylobacterfetusmeningitisconfirmedbya16srrnageneanalysisusingtheminionnanoporesequencersouthkorea
‡A
Campylobacter fetus meningitis confirmed by a 16S rRNA gene analysis using the MinION nanopore sequencer, South Korea, 2016.
‡9
1
|
|
919
|
|
|
‡a
capabilityofarterialspinlabelingmrimaginginlocalizingseizurefocusinclinicalseizureactivity
‡A
Capability of arterial spin labeling MR imaging in localizing seizure focus in clinical seizure activity
‡9
1
|
|
919
|
|
|
‡a
cardiacsympatheticdysfunctioninantinmdareceptorencephalitis
‡A
Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis
‡9
1
|
|
919
|
|
|
‡a
caseofrickettsiatyphiinducedbrainabscessmimickingbraintumor
‡A
Case of Rickettsia typhi-induced Brain Abscess Mimicking Brain Tumor.
‡9
1
|
|
919
|
|
|
‡a
celecoxibinducesfunctionalrecoveryafterintracerebralhemorrhagewithreductionofbrainedemaandperihematomalcelldeath
‡A
Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death
‡9
1
|
|
919
|
|
|
‡a
cellproliferationandsynaptogenesisinthecerebellumafterfocalcerebralischemia
‡A
Cell proliferation and synaptogenesis in the cerebellum after focal cerebral ischemia.
‡9
1
|
|
919
|
|
|
‡a
centralnervoussystemcomplicationsafterlivertransplantation
‡A
Central nervous system complications after liver transplantation.
‡9
1
|
|
919
|
|
|
‡a
centralnervoussysteminfectionassociatedwithorientiatsutsugamushiinsouthkorea
‡A
Central Nervous System Infection Associated with Orientia tsutsugamushi in South Korea.
‡9
1
|
|
919
|
|
|
‡a
cerebralautoinflammatorydiseasetreatedwithanakinra
‡A
Cerebral autoinflammatory disease treated with anakinra.
‡9
1
|
|
919
|
|
|
‡a
changeofpatientselectionstrategyandimprovedsurgicaloutcomeinmrinegativeneocorticalepilepsy
‡A
Change of Patient Selection Strategy and Improved Surgical Outcome in MRI-negative Neocortical Epilepsy
‡9
1
|
|
919
|
|
|
‡a
characteristicsofepilepsypatientswhocommittedviolentcrimesreportfromthenationalforensichospital
‡A
Characteristics of Epilepsy Patients who Committed Violent Crimes: Report from the National Forensic Hospital
‡9
1
|
|
919
|
|
|
‡a
cholinergicantiinflammatorypathwayinintracerebralhemorrhage
‡A
Cholinergic anti-inflammatory pathway in intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
circulatingcd62e+microparticlesandcardiovascularoutcomes
‡A
Circulating CD62E+ microparticles and cardiovascular outcomes
‡9
1
|
|
919
|
|
|
‡a
circulatingendothelialmicroparticlesasamarkerofcerebrovasculardisease
‡A
Circulating endothelial microparticles as a marker of cerebrovascular disease.
‡9
1
|
|
919
|
|
|
‡a
circulatingendothelialprogenitorcellsasanewmarkerofendothelialdysfunctionorrepairinacutestroke
‡A
Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke
‡9
1
|
|
919
|
|
|
‡a
circulatingendothelialprogenitorcellsasapathogeneticmarkerofmoyamoyadisease
‡A
Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease
‡9
1
|
|
919
|
|
|
‡a
clinicalandangiographicfactorsrelatedtotheprognosisofcavernoussinusduralarteriovenousfistula
‡A
Clinical and angiographic factors related to the prognosis of cavernous sinus dural arteriovenous fistula
‡9
1
|
|
919
|
|
|
‡a
clinicalapplicationsofsimultaneouspetmrimagingusingrverapamilwithcyclosporinapreliminaryresultsonasurrogatemarkerofdrugresistantepilepsy
‡A
Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy.
‡9
1
|
|
919
|
|
|
‡a
clinicalapproachtoautoimmuneepilepsy
‡A
Clinical Approach to Autoimmune Epilepsy
‡9
1
|
|
919
|
|
|
‡a
clinicalcharacteristicsofseverejapaneseencephalitisacaseseriesfromsouthkorea
‡A
Clinical Characteristics of Severe Japanese Encephalitis: A Case Series from South Korea.
‡9
1
|
|
919
|
|
|
‡a
clinicalcharacterizationofunknowncryptogenicstatusepilepticussuspectedasencephalitisamulticentercohortstudy
‡A
Clinical characterization of unknown/cryptogenic status epilepticus suspected as encephalitis: A multicenter cohort study.
‡9
1
|
|
919
|
|
|
‡a
clinicalmanifestationofcancerrelatedstrokeretrospectivecasecontrolstudy
‡A
Clinical manifestation of cancer related stroke: retrospective case-control study
‡9
1
|
|
919
|
|
|
‡a
clinicalmanifestationsandoutcomesofthetreatmentofpatientswithgababencephalitis
‡A
Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis
‡9
1
|
|
919
|
|
|
‡a
clinicalmanifestationsandtreatmentoutcomesofparvovirusb19encephalitisinimmunocompetentadults
‡A
Clinical manifestations and treatment outcomes of parvovirus B19 encephalitis in immunocompetent adults.
‡9
1
|
|
919
|
|
|
‡a
clinicalmanifestationsofpatientswithcaspr2antibodies
‡A
Clinical manifestations of patients with CASPR2 antibodies.
‡9
1
|
|
919
|
|
|
‡a
clinicalobservationoflymphopeniainpatientswithnewlydiagnosedglioblastoma
‡A
Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma
‡9
1
|
|
919
|
|
|
‡a
clusteringofspontaneousrecurrentseizuresseparatedbylongseizurefreeperiodsanextendedvideoeegmonitoringstudyofapilocarpinemousemodel
‡A
Clustering of spontaneous recurrent seizures separated by long seizure-free periods: An extended video-EEG monitoring study of a pilocarpine mouse model.
‡9
1
|
|
919
|
|
|
‡a
combinedneuroprotectiveeffectsofcelecoxibandmemantineinexperimentalintracerebralhemorrhage
‡A
Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
combinedtreatmentofvascularendothelialgrowthfactorandhumanneuralstemcellsinexperimentalfocalcerebralischemia
‡A
Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia
‡9
1
|
|
919
|
|
|
‡a
comorbiddepressionisassociatedwithanegativetreatmentresponseinidiopathicremsleepbehaviordisorder
‡A
Comorbid Depression Is Associated with a Negative Treatment Response in Idiopathic REM Sleep Behavior Disorder
‡9
1
|
|
919
|
|
|
‡a
comparisonofgeneticprofilesandprognosisofhighgradegliomasusingquantitativeandqualitativemrifeaturesafocusong3gliomas
‡A
Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas
‡9
1
|
|
919
|
|
|
‡a
continuouscytosineb500arabinofuranosideinfusionreducesectopicgranulecellsinadultrathippocampuswithattenuationofspontaneousrecurrentseizuresfollowingpilocarpineinducedstatusepilepticus
‡A
Continuous cytosine-b-D-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
‡9
1
|
|
919
|
|
|
‡a
correctionclusteringofspontaneousrecurrentseizuresseparatedbylongseizurefreeperiodsanextendedvideoeegmonitoringstudyofapilocarpinemousemodel
‡A
Correction: Clustering of spontaneous recurrent seizures separated by long seizure-free periods: An extended video-EEG monitoring study of a pilocarpine mouse model
‡9
1
|
|
919
|
|
|
‡a
correctiondirectgenerationofneurospherelikecellsfromhumandermalfibroblasts
‡A
Correction: Direct Generation of Neurosphere-Like Cells from Human Dermal Fibroblasts
‡9
1
|
|
919
|
|
|
‡a
corrigendumtoalteredrestingstatethalamooccipitalfunctionalconnectivityisassociatedwithcognitioninisolatedrapideyemovementsleepbehaviordisorder
‡A
Corrigendum to "Altered resting-state thalamo-occipital functional connectivity is associated with cognition in isolated rapid eye movement sleep behavior disorder" [Sleep Med 69 (2020) 198-203]
‡9
1
|
|
919
|
|
|
‡a
criminalmanifestationsofdementiapatientsreportfromthenationalforensichospital
‡A
Criminal manifestations of dementia patients: report from the national forensic hospital
‡9
1
|
|
919
|
|
|
‡a
cyclooxygenase2inhibitorcelecoxibinhibitsthealteredhippocampalneurogenesiswithattenuationofspontaneousrecurrentseizuresfollowingpilocarpineinducedstatusepilepticus
‡A
Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
‡9
1
|
|
919
|
|
|
‡a
cystatin100apotentialmarkerforcerebralmicrovascularcomplianceisassociatedwithwhitematterhyperintensitiesprogression
‡A
Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression.
‡9
1
|
|
919
|
|
|
‡a
delayedorthostatichypotensionseverityofclinicalsymptomsandresponsetomedicaltreatment
‡A
Delayed orthostatic hypotension: Severity of clinical symptoms and response to medical treatment
‡9
1
|
|
919
|
|
|
‡a
deleterious100cblexonskippingcontributestohumanglioma
‡A
Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.
‡9
1
|
|
919
|
|
|
‡a
depletionofnervegrowthfactorinchemotherapyinducedperipheralneuropathyassociatedwithhematologicmalignancies
‡A
Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies
‡9
1
|
|
919
|
|
|
‡a
developmentoflgi1antibodyencephalitisaftertreatmentoflungcancer
‡A
Development of LGI1 antibody encephalitis after treatment of lung cancer
‡9
1
|
|
919
|
|
|
‡a
developmentoftheclinicalassessmentscaleinautoimmuneencephalitis
‡A
Development of the clinical assessment scale in autoimmune encephalitis
‡9
1
|
|
919
|
|
|
‡a
diagnosisofhaemophilusinfluenzaepneumoniabynanopore16sampliconsequencingofsputum
‡A
Diagnosis of Haemophilus influenzae Pneumonia by Nanopore 16S Amplicon Sequencing of Sputum
‡9
1
|
|
919
|
|
|
‡a
differentiationofhighgradefromlowgradeastrocytomaimprovementindiagnosticaccuracyandreliabilityofpharmacokineticparametersfromdcemrimagingbyusingarterialinputfunctionsobtainedfromdscmrimaging
‡A
Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
‡9
1
|
|
919
|
|
|
‡a
directgenerationofneurospherelikecellsfromhumandermalfibroblasts
‡A
Direct generation of neurosphere-like cells from human dermal fibroblasts
‡9
1
|
|
919
|
|
|
‡a
distinctexpressionoflongnoncodingrnasinanalzheimersdiseasemodel
‡A
Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
‡9
1
|
|
919
|
|
|
‡a
distinctintrathecalinterleukin17interleukin6activationinantinmethyl500aspartatereceptorencephalitis
‡A
Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
‡9
1
|
|
919
|
|
|
‡a
dynamiccontrastenhancedmrimaginginpredictingprogressionofenhancinglesionspersistingafterstandardtreatmentinglioblastomapatientsaprospectivestudy
‡A
Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.
‡9
1
|
|
919
|
|
|
‡a
dynamiccontrastenhancedmrimagingofnonenhancingt2highsignalintensitylesionsinbaselineandposttreatmentglioblastomatemporalchangeandprognosticvalue
‡A
Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value
‡9
1
|
|
919
|
|
|
‡a
dysfunctionalcharacteristicsofcirculatingangiogeniccellsinalzheimersdisease
‡A
Dysfunctional characteristics of circulating angiogenic cells in Alzheimer's disease.
‡9
1
|
|
919
|
|
|
‡a
dysregulatedlongnoncodingrnasinthetemporallobeepilepsymousemodel
‡A
Dysregulated long non-coding RNAs in the temporal lobe epilepsy mouse model.
‡9
1
|
|
919
|
|
|
‡a
dysregulationoflongnoncodingrnasinmousemodelsoflocalizationrelatedepilepsy
‡A
Dysregulation of long non-coding RNAs in mouse models of localization-related epilepsy.
‡9
1
|
|
919
|
|
|
‡a
earlydiagnosisofalzheimersdiseasefromelevatedolfactorymucosalmir206level
‡A
Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level.
‡9
1
|
|
919
|
|
|
‡a
earlyintravenousinfusionofsodiumnitriteprotectsbrainagainstinvivoischemiareperfusioninjury
‡A
Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury
‡9
1
|
|
919
|
|
|
‡a
echocardiographicevidenceofinnateaortopathyinthehumanintracranialaneurysm
‡A
Echocardiographic evidence of innate aortopathy in the human intracranial aneurysm
‡9
1
|
|
919
|
|
|
‡a
echocardiographicindexeeinassociationwithcerebralwhitematterhyperintensityprogression
‡A
Echocardiographic index E/e' in association with cerebral white matter hyperintensity progression
‡9
1
|
|
919
|
|
|
‡a
effectofimmunotherapyonseizureoutcomeinpatientswithautoimmuneencephalitisaprospectiveobservationalregistrystudy
‡A
Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study
‡9
1
|
|
919
|
|
|
‡a
effectsoflongtermnitritetherapyonfunctionalrecoveryinexperimentalischemiamodel
‡A
Effects of long term nitrite therapy on functional recovery in experimental ischemia model.
‡9
1
|
|
919
|
|
|
‡a
efficacyofatomoxetineversusmidodrineforneurogenicorthostatichypotension
‡A
Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
‡9
1
|
|
919
|
|
|
‡a
efficacyofpropranololbisoprololandpyridostigmineforposturaltachycardiasyndromearandomizedclinicaltrial
‡A
Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
‡9
1
|
|
919
|
|
|
‡a
efficacyofsingleorcombinedmidodrineandpyridostigmineinorthostatichypotension
‡A
Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension
‡9
1
|
|
919
|
|
|
‡a
erratumtolossofpericytesinradiationnecrosisafterglioblastomatreatments
‡A
Erratum to: Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.
‡9
1
|
|
919
|
|
|
‡a
erythropoietinimprovesmemoryfunctionwithreducingendothelialdysfunctionandamyloidbetaburdeninalzheimersdiseasemodels
‡A
Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models
‡9
1
|
|
919
|
|
|
‡a
erythropoietinreducesepileptogenicprocessesfollowingstatusepilepticus
‡A
Erythropoietin reduces epileptogenic processes following status epilepticus
‡9
1
|
|
919
|
|
|
‡a
erythropoietinreducesperihematomalinflammationandcelldeathwithenosandstat3activationsinexperimentalintracerebralhemorrhage
‡A
Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
etiologyandprognosisofnonconvulsivestatusepilepticus
‡A
Etiology and prognosis of non-convulsive status epilepticus
‡9
1
|
|
919
|
|
|
‡a
exosomebaseddeliveryofmir124inahuntingtonsdiseasemodel
‡A
Exosome-Based Delivery of miR-124 in a Huntington's Disease Model
‡9
1
|
|
919
|
|
|
‡a
experimentalinductionofcerebralaneurysmsbydevelopmentallowcopperdiet
‡A
Experimental Induction of Cerebral Aneurysms by Developmental Low Copper Diet
‡9
1
|
|
919
|
|
|
‡a
extractsofadiposederivedstemcellsslowsprogressioninther62modelofhuntingtonsdisease
‡A
Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
fatalfamilialinsomniapresentingwithagrypniaexcitataandverylowatoniaindexlevelacasereportandliteraturereview
‡A
Fatal familial insomnia presenting with agrypnia excitata and very low atonia index level: A case report and literature review
‡9
1
|
|
919
|
|
|
‡a
feasibilityandsafetyofintraarterialpericyteprogenitorcelldeliveryfollowingmannitolinducedtransientbloodbrainbarrieropeninginacaninemodel
‡A
Feasibility and Safety of Intra-arterial Pericyte Progenitor Cell Delivery Following Mannitol-Induced Transient Blood-Brain Barrier Opening in a Canine Model
‡9
1
|
|
919
|
|
|
‡a
frequencyofandriskfactorsforoxcarbazepineinducedsevereandsymptomatichyponatremia
‡A
Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia
‡9
1
|
|
919
|
|
|
‡a
frequentrhabdomyolysisinantinmdareceptorencephalitis
‡A
Frequent rhabdomyolysis in anti-NMDA receptor encephalitis
‡9
1
|
|
919
|
|
|
‡a
gcsfprotectshumancerebralhybridneuronsagainstinvitroischemia
‡A
G-CSF protects human cerebral hybrid neurons against in vitro ischemia
‡9
1
|
|
919
|
|
|
‡a
galantaminereducesstriataldegenerationin3nitropropionicacidmodelofhuntingtonsdisease
‡A
Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
‡9
1
|
|
919
|
|
|
‡a
gammaoscillationinfunctionalbrainnetworksisinvolvedinthespontaneousremissionofdepressivebehaviorinducedbychronicrestraintstressinmice
‡A
Gamma oscillation in functional brain networks is involved in the spontaneous remission of depressive behavior induced by chronic restraint stress in mice
‡9
1
|
|
919
|
|
|
‡a
granulocytecolonystimulatingfactorattenuatesstriataldegenerationwithactivatingsurvivalpathwaysin3nitropropionicacidmodelofhuntingtonsdisease
‡A
Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
granulocytecolonystimulatingfactorenhancesangiogenesisafterfocalcerebralischemia
‡A
Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia
‡9
1
|
|
919
|
|
|
‡a
granulocytecolonystimulatingfactorinducessensorimotorrecoveryinintracerebralhemorrhage
‡A
Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
granulocytecolonystimulatingfactorstimulatesneurogenesisviavascularendothelialgrowthfactorwithstatactivation
‡A
Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation
‡9
1
|
|
919
|
|
|
‡a
heatprocessedginsengenhancesthecognitivefunctioninpatientswithmoderatelyseverealzheimersdisease
‡A
Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease.
‡9
1
|
|
919
|
|
|
‡a
highalbuminlevelisapredictoroffavorableresponsetoimmunotherapyinautoimmuneencephalitis
‡A
High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
‡9
1
|
|
919
|
|
|
‡a
highcellfreednalevelsincerebrospinalfluidpredictleptomeningealseedingofhematologicmalignancy
‡A
High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy
‡9
1
|
|
919
|
|
|
‡a
highfatdietandvoluntarychronicaerobicexerciserecoveralteredlevelsofagingrelatedtryptophanmetabolitesalongthekynureninepathway
‡A
High-Fat Diet and Voluntary Chronic Aerobic Exercise Recover Altered Levels of Aging-Related Tryptophan Metabolites along the Kynurenine Pathway
‡9
1
|
|
919
|
|
|
‡a
hlaa1101isassociatedwithlevetiracetaminducedpsychiatricadverseevents
‡A
HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events
‡9
1
|
|
919
|
|
|
‡a
hlaa3101andlamotrigineinducedseverecutaneousadversedrugreactionsinakoreanpopulation
‡A
HLA-A*31:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population
‡9
1
|
|
919
|
|
|
‡a
hlab4002anddrb10403areriskfactorsforoxcarbazepineinducedmaculopapulareruption
‡A
HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption
‡9
1
|
|
919
|
|
|
‡a
hlab27associationofautoimmuneencephalitisinducedbypdl1inhibitor
‡A
HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor
‡9
1
|
|
919
|
|
|
‡a
hlasassociatedwithperampanelinducedpsychiatricadverseeffectsinakoreanpopulation
‡A
HLAs associated with perampanel-induced psychiatric adverse effects in a Korean population
‡9
1
|
|
919
|
|
|
‡a
hmgcoareductaseinhibitoratorvastatinpromotessensorimotorrecoverysuppressingacuteinflammatoryreactionafterexperimentalintracerebralhemorrhage
‡A
HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
humanembryonicstemcellderivedneuralprecursortransplantsattenuateapomorphineinducedrotationalbehaviorinratswithunilateralquinolinicacidlesions
‡A
Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions
‡9
1
|
|
919
|
|
|
‡a
humanleukocyteantigenassociationsinposturaltachycardiasyndrome
‡A
Human leukocyte antigen associations in postural tachycardia syndrome
‡9
1
|
|
919
|
|
|
‡a
humanneuralstemcelltransplantationreducesspontaneousrecurrentseizuresfollowingpilocarpineinducedstatusepilepticusinadultrats
‡A
Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats
‡9
1
|
|
919
|
|
|
‡a
humanneuralstemcellsimprovesensorimotordeficitsintheadultratbrainwithexperimentalfocalischemia
‡A
Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia
‡9
1
|
|
919
|
|
|
‡a
ictalasystoleandeatingreflexseizureswithtemporallobeepilepsy
‡A
Ictal asystole and eating reflex seizures with temporal lobe epilepsy.
‡9
1
|
|
919
|
|
|
‡a
identificationofcerebralperfusionusingarterialspinlabelinginpatientswithseizuresinacutesettings
‡A
Identification of cerebral perfusion using arterial spin labeling in patients with seizures in acute settings
‡9
1
|
|
919
|
|
|
‡a
identificationofneuronaloutgrowthcellsfromperipheralbloodofstrokepatients
‡A
Identification of neuronal outgrowth cells from peripheral blood of stroke patients.
‡9
1
|
|
919
|
|
|
‡a
impactofaselectivecyclooxygenase2inhibitorcelecoxiboncorticalexcitabilityandelectrophysiologicalpropertiesofthebraininhealthyvolunteersarandomizeddoubleblindplacebocontrolledstudy
‡A
Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study
‡9
1
|
|
919
|
|
|
‡a
impactofinterimprogressionduringthesurgerytoradiotherapyintervalanditspredictorsinglioblastomatreatedwithtemozolomidebasedradiochemotherapy
‡A
Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy.
‡9
1
|
|
919
|
|
|
‡a
impactofstrokemechanisminacutebasilarocclusionwithreperfusiontherapy
‡A
Impact of stroke mechanism in acute basilar occlusion with reperfusion therapy.
‡9
1
|
|
919
|
|
|
‡a
improvementofcognitivedeficitinalzheimersdiseasepatientsbylongtermtreatmentwithkoreanredginseng
‡A
Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with korean red ginseng
‡9
1
|
|
919
|
|
|
‡a
increasedadverseeventsassociatedwithantiepilepticdrugsinantileucinerichgliomainactivatedprotein1encephalitis
‡A
Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis
‡9
1
|
|
919
|
|
|
‡a
increasedarterialpulsatilityandprogressionofsinglesubcorticalinfarction
‡A
Increased arterial pulsatility and progression of single subcortical infarction.
‡9
1
|
|
919
|
|
|
‡a
increasedcirculatingendothelialmicroparticlesandcarotidatherosclerosisinobstructivesleepapnea
‡A
Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea.
‡9
1
|
|
919
|
|
|
‡a
increasingprevalenceofantimicrobialresistanceinurinarytractinfectionsofneurologicalpatientsseoulsouthkorea2007
‡A
Increasing prevalence of antimicrobial resistance in urinary tract infections of neurological patients, Seoul, South Korea, 2007-2016
‡9
1
|
|
919
|
|
|
‡a
inductionofburstsuppressionorcomausingintravenousanestheticsinrefractorystatusepilepticus
‡A
Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus
‡9
1
|
|
919
|
|
|
‡a
inhibitionoflet7cmicrornaisneuroprotectiveinaratintracerebralhemorrhagemodel
‡A
Inhibition of Let7c microRNA is neuroprotective in a rat intracerebral hemorrhage model
‡9
1
|
|
919
|
|
|
‡a
inhibitionofmir203reducesspontaneousrecurrentseizuresinmice
‡A
Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice
‡9
1
|
|
919
|
|
|
‡a
intrathecalspecificglutamicaciddecarboxylaseantibodiesatlowtitersinautoimmuneneurologicaldisorders
‡A
Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
‡9
1
|
|
919
|
|
|
‡a
intravenousadministrationofhumanneuralstemcellsinducesfunctionalrecoveryinhuntingtonsdiseaseratmodel
‡A
Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model
‡9
1
|
|
919
|
|
|
‡a
isolatedandprolongedlossoftimeorientation
‡A
Isolated and prolonged loss of time orientation
‡9
1
|
|
919
|
|
|
‡a
let7micrornainhibitstheproliferationofhumanglioblastomacells
‡A
Let-7 microRNA inhibits the proliferation of human glioblastoma cells
‡9
1
|
|
919
|
|
|
‡a
lgi1expressionandhumanbrainasymmetryinsightsfrompatientswithlgi1antibodyencephalitis
‡A
LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
‡9
1
|
|
919
|
|
|
‡a
lightinducedamaurosisfugaxduetoseveredistalinternalcarotidarterystenosisinviewofmanagingocularischemicsyndrome
‡A
Light-induced amaurosis fugax due to severe distal internal carotid artery stenosis: in view of managing ocular ischemic syndrome.
‡9
1
|
|
919
|
|
|
‡a
lossofpericytesinradiationnecrosisafterglioblastomatreatments
‡A
Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.
‡9
1
|
|
919
|
|
|
‡a
maternalimmuneactivationaltersbrainmicrornaexpressioninmouseoffspring
‡A
Maternal immune activation alters brain microRNA expression in mouse offspring
‡9
1
|
|
919
|
|
|
‡a
mefloquineimprovedprogressivemultifocalleukoencephalopathyinapatientwithimmunoglobulinanephropathy
‡A
Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy
‡9
1
|
|
919
|
|
|
‡a
megadosephenobarbitaltherapyforsuperrefractorystatusepilepticus
‡A
Mega-dose phenobarbital therapy for super-refractory status epilepticus
‡9
1
|
|
919
|
|
|
‡a
memantinereduceshematomaexpansioninexperimentalintracerebralhemorrhageresultinginfunctionalimprovement
‡A
Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement
‡9
1
|
|
919
|
|
|
‡a
memantinereducesstriatalcelldeathwithdecreasingcalpainlevelin3nitropropionicmodelofhuntingtonsdisease
‡A
Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
micrornasinducedduringischemicpreconditioning
‡A
MicroRNAs induced during ischemic preconditioning
‡9
1
|
|
919
|
|
|
‡a
mir206regulatesbrainderivedneurotrophicfactorinalzheimerdiseasemodel
‡A
miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model
‡9
1
|
|
919
|
|
|
‡a
modulationofmitochondrialfunctionbystemcellderivedcellularcomponents
‡A
Modulation of mitochondrial function by stem cell-derived cellular components.
‡9
1
|
|
919
|
|
|
‡a
mogantibodyassociatedencephalitisinadultclinicalphenotypesandoutcomes
‡A
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes
‡9
1
|
|
919
|
|
|
‡a
molecularalterationsunderlyingepileptogenesisafterprolongedfebrileseizureandmodulationbyerythropoietin
‡A
Molecular alterations underlying epileptogenesis after prolonged febrile seizure and modulation by erythropoietin.
‡9
1
|
|
919
|
|
|
‡a
mrimaginganalysisofnonmeasurableenhancinglesionsnewlyappearingafterconcomitantchemoradiotherapyinglioblastomapatientsforprognosisprediction
‡A
MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction
‡9
1
|
|
919
|
|
|
‡a
multidrugresistanceprotein1reducestheaggregationofmutanthuntingtininneuronalcellsderivedfromthehuntingtonsdiseaser62model
‡A
Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model
‡9
1
|
|
919
|
|
|
‡a
multipotentpdgfrβexpressingcellsinthecirculationofstrokepatients
‡A
Multipotent PDGFRβ-expressing cells in the circulation of stroke patients
‡9
1
|
|
919
|
|
|
‡a
neurobehcetsdiseasemimickingmultiplebraintumorsdiffusionweightedmrstudyandliteraturereview
‡A
Neuro-Behcet's disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review
‡9
1
|
|
919
|
|
|
‡a
neuropathologicandclinicalfeaturesofhumanmedialtemporallobeepilepsy
‡A
Neuropathologic and clinical features of human medial temporal lobe epilepsy.
‡9
1
|
|
919
|
|
|
‡a
neuroprotectiveeffectofacellfreeextractderivedfromhumanadiposestemcellsinexperimentalstrokemodels
‡A
Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models
‡9
1
|
|
919
|
|
|
‡a
neuroprotectiveeffectofneuralstemcellconditionedmediaininvitromodelofhuntingtonsdisease
‡A
Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
neurotoxicsyndromedevelopedaftertakingsertralineandrisperidone
‡A
Neurotoxic syndrome developed after taking sertraline and risperidone
‡9
1
|
|
919
|
|
|
‡a
neurovascularcellsheettransplantationinacaninemodelofintracranialhemorrhage
‡A
Neurovascular Cell Sheet Transplantation in a Canine Model of Intracranial Hemorrhage
‡9
1
|
|
919
|
|
|
‡a
newconceptofneuralstemcelltransplantationantiinflammatoryrole
‡A
New Concept of Neural Stem Cell Transplantation: Anti-inflammatory Role.
‡9
1
|
|
919
|
|
|
‡a
newfeasibletreatmentforrefractoryautoimmuneencephalitislowdoseinterleukin2
‡A
New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2.
‡9
1
|
|
919
|
|
|
‡a
nonstiffantiamphiphysinsyndromeclinicalmanifestationsandoutcomeafterimmunotherapy
‡A
Non-stiff anti-amphiphysin syndrome: clinical manifestations and outcome after immunotherapy
‡9
1
|
|
919
|
|
|
‡a
noninvasivemethodofimmortalizedneuralstemlikecelltransplantationinanexperimentalmodelofhuntingtonsdisease
‡A
Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
novelmutationintheatl1withautosomaldominanthereditaryspasticparaplegiapresentedasdysautonomia
‡A
Novel mutation in the ATL1 with autosomal dominant hereditary spastic paraplegia presented as dysautonomia.
‡9
1
|
|
919
|
|
|
‡a
novelrecursivepartitioninganalysisclassificationfornewlydiagnosedglioblastomaamultiinstitutionalstudyhighlightingthemgmtpromotermethylationandidh1genemutationstatus
‡A
Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status
‡9
1
|
|
919
|
|
|
‡a
nremsleepeegoscillationsinidiopathicremsleepbehaviordisorderastudyofsleepspindlesandslowoscillations
‡A
NREM Sleep EEG Oscillations in Idiopathic REM Sleep Behavior Disorder: A study of sleep spindles and slow oscillations
‡9
1
|
|
919
|
|
|
‡a
nuclearlocalizationofhuntingtinduringspermatogenesis
‡A
Nuclear localization of huntingtin during spermatogenesis
‡9
1
|
|
919
|
|
|
‡a
orthostaticintolerancesymptomsareassociatedwithdepressionanddiminishedqualityoflifeinpatientswithposturaltachycardiasyndrome
‡A
Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome
‡9
1
|
|
919
|
|
|
‡a
panaxginsengenhancescognitiveperformanceinalzheimerdisease
‡A
Panax ginseng enhances cognitive performance in Alzheimer disease.
‡9
1
|
|
919
|
|
|
‡a
paradoxicalchoroidplexitisduringtreatmentfortuberculousmeningoencephalitis
‡A
Paradoxical Choroid Plexitis during Treatment for Tuberculous Meningoencephalitis
‡9
1
|
|
919
|
|
|
‡a
periodicityofcerebralflowvelocityduringsleepanditsassociationwithwhitematterhyperintensityvolume
‡A
Periodicity of cerebral flow velocity during sleep and its association with white-matter hyperintensity volume
‡9
1
|
|
919
|
|
|
‡a
peroxisomeproliferatoractivatedreceptorgammaagonistrosiglitazonepromotesangiogenesisafterfocalcerebralischemia
‡A
Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
‡9
1
|
|
919
|
|
|
‡a
pharmacologicalinductionofheatshockproteinexertsneuroprotectiveeffectsinexperimentalintracerebralhemorrhage
‡A
Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage
‡9
1
|
|
919
|
|
|
‡a
pharmacologicalinductionofischemictolerancebyglutamatetransporter1
‡A
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1
‡9
1
|
|
919
|
|
|
‡a
pharmacologicalinductionofischemictolerancebyglutamatetransporter1eaat2upregulation
‡A
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation
‡9
1
|
|
919
|
|
|
‡a
pharmacologicaltreatmentofepilepsyinelderlypatients
‡A
Pharmacological Treatment of Epilepsy in Elderly Patients
‡9
1
|
|
919
|
|
|
‡a
pneumoniainhospitalizedneurologicpatientstrendsinpathogendistributionandantibioticsusceptibility
‡A
Pneumonia in hospitalized neurologic patients: trends in pathogen distribution and antibiotic susceptibility
‡9
1
|
|
919
|
|
|
‡a
populationpharmacokineticsanddoseresponserelationshipoflevetiracetaminadultpatientswithepilepsy
‡A
Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy
‡9
1
|
|
919
|
|
|
‡a
possibleepigeneticregulatoryeffectofdysregulatedcircularrnasinalzheimersdiseasemodel
‡A
Possible epigenetic regulatory effect of dysregulated circular RNAs in Alzheimer's disease model
‡9
1
|
|
919
|
|
|
‡a
possibleepigeneticregulatoryeffectofdysregulatedcircularrnasinepilepsy
‡A
Possible epigenetic regulatory effect of dysregulated circular RNAs in epilepsy
‡9
1
|
|
919
|
|
|
‡a
predictorsofsurvivalforpatientswithcanceraftercryptogenicstroke
‡A
Predictors of survival for patients with cancer after cryptogenic stroke
‡9
1
|
|
919
|
|
|
‡a
prevalenceofantineuronalantibodiesinpatientswithencephalopathyofunknownetiologydatafromanationwideregistryinkorea
‡A
Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in Korea.
‡9
1
|
|
919
|
|
|
‡a
profilesofmultidrugresistanceprotein1intheperipheralbloodmononuclearcellsofpatientswithrefractoryepilepsy
‡A
Profiles of multidrug resistance protein-1 in the peripheral blood mononuclear cells of patients with refractory epilepsy
‡9
1
|
|
919
|
|
|
‡a
prognosisofspontaneouscervicalarterydissectionandtranscranialdopplerfindingsassociatedwithclinicaloutcomes
‡A
Prognosis of spontaneous cervical artery dissection and transcranial Doppler findings associated with clinical outcomes
‡9
1
|
|
919
|
|
|
‡a
usefulnessofsalivaforperampaneltherapeuticdrugmonitoring
‡A
Usefulness of saliva for perampanel therapeutic drug monitoring
‡9
1
|
|
919
|
|
|
‡a
prognosispredictionofnonenhancingt2highsignalintensitylesionsinglioblastomapatientsafterstandardtreatmentapplicationofdynamiccontrastenhancedmrimaging
‡A
Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
‡9
1
|
|
919
|
|
|
‡a
prognosticpredictionsforpatientswithglioblastomaafterstandardtreatmentapplicationofcontrastleakageinformationfromdscmriwithinnonenhancingflairhighsignalintensitylesions
‡A
Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions
‡9
1
|
|
919
|
|
|
‡a
prognosticvalueofinitialstandardeegandmriinpatientswithherpessimplexencephalitis
‡A
Prognostic Value of Initial Standard EEG and MRI in Patients with Herpes Simplex Encephalitis
‡9
1
|
|
919
|
|
|
‡a
progressionofcerebralwhitematterhyperintensitiesandtheassociatedsonographicindex
‡A
Progression of Cerebral White Matter Hyperintensities and the Associated Sonographic Index
‡9
1
|
|
919
|
|
|
‡a
prolongedreleasemelatonininpatientswithidiopathicremsleepbehaviordisorder
‡A
Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder
‡9
1
|
|
919
|
|
|
‡a
proteasomalinhibitioninintracerebralhemorrhageneuroprotectiveandantiinflammatoryeffectsofbortezomib
‡A
Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib
‡9
1
|
|
919
|
|
|
‡a
psychiatricsymptomsdelaythediagnosisofantilgi1encephalitis
‡A
Psychiatric symptoms delay the diagnosis of anti-LGI1 encephalitis.
‡9
1
|
|
919
|
|
|
‡a
quantificationofhumanneuralstemcellengraftmentsinratbrainsusingerv3realtimepcr
‡A
Quantification of human neural stem cell engraftments in rat brains using ERV-3 real-time PCR.
‡9
1
|
|
919
|
|
|
‡a
radiogenomicscorrelationbetweenmrimagingfeaturesandmajorgeneticprofilesinglioblastoma
‡A
Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.
‡9
1
|
|
919
|
|
|
‡a
rapiddiagnosisofbacterialmeningitisbynanopore16sampliconsequencingapilotstudy
‡A
Rapid diagnosis of bacterial meningitis by nanopore 16S amplicon sequencing: A pilot study
‡9
1
|
|
919
|
|
|
‡a
reducedp300amplitudeduringavisuospatialattentiontaskinidiopathicrapideyemovementsleepbehaviordisorder
‡A
Reduced P300 amplitude during a visuospatial attention task in idiopathic rapid eye movement sleep behavior disorder.
‡9
1
|
|
919
|
|
|
‡a
reemergenceofjapaneseencephalitisinsouthkorea2010
‡A
Reemergence of Japanese Encephalitis in South Korea, 2010–2015
‡9
1
|
|
919
|
|
|
‡a
refininggeneralprinciplesofantiepilepticdrugtreatmentsforepilepsy
‡A
Refining General Principles of Antiepileptic Drug Treatments for Epilepsy
‡9
1
|
|
919
|
|
|
‡a
regionspecificplasticityintheepilepticratbrainahippocampalandextrahippocampalanalysis
‡A
Region-specific plasticity in the epileptic rat brain: a hippocampal and extrahippocampal analysis
‡9
1
|
|
919
|
|
|
‡a
replytogradingtheseverityofautoimmuneencephalitisadvancesandpitfalls
‡A
Reply to "Grading the severity of autoimmune encephalitis: Advances and pitfalls"
‡9
1
|
|
919
|
|
|
‡a
replytogradingtheseverityofautoimmuneencephalitiswhentoevaluate
‡A
Reply to "Grading the Severity of Autoimmune Encephalitis: When to Evaluate?"
‡9
1
|
|
919
|
|
|
‡a
rhythmicalphoticstimulationat Alpha frequenciesproducesantidepressantlikeeffectsinamousemodelofdepression
‡A
Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effects in a Mouse Model of Depression
‡9
1
|
|
919
|
|
|
‡a
riskofmacrovascularcomplicationsintype2diabetesmellitusendothelialmicroparticleprofiles
‡A
Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles
‡9
1
|
|
919
|
|
|
‡a
rituximabtreatmentforautoimmunelimbicencephalitisinaninstitutionalcohort
‡A
Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
‡9
1
|
|
919
|
|
|
‡a
rituximabtreatmentforidiopathichypertrophicpachymeningitis
‡A
Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis
‡9
1
|
|
919
|
|
|
‡a
roleofcorticaldysplasiainepileptogenesisfollowingprolongedfebrileseizure
‡A
Role of cortical dysplasia in epileptogenesis following prolonged febrile seizure
‡9
1
|
|
919
|
|
|
‡a
safetyoftianeptineuseinpatientswithepilepsy
‡A
Safety of tianeptine use in patients with epilepsy
‡9
1
|
|
919
|
|
|
‡a
screeningofthea11084gpolymorphismandscanningofamitochondrialgenomesnpinkoreanmigraineurs
‡A
Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs
‡9
1
|
|
919
|
|
|
‡a
valproicacidmediatedneuroprotectioninintracerebralhemorrhageviahistonedeacetylaseinhibitionandtranscriptionalactivation
‡A
Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
‡9
1
|
|
919
|
|
|
‡a
seronegativeautoimmuneencephalitisclinicalcharacteristicsandfactorsassociatedwithoutcomes
‡A
Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes
‡9
1
|
|
919
|
|
|
‡a
sitespecificrelationshipbetweenintracranialaneurysmandaorticaneurysm
‡A
Site-Specific Relationship Between Intracranial Aneurysm and Aortic Aneurysm
‡9
1
|
|
919
|
|
|
‡a
slowedprogressioninmodelsofhuntingtondiseasebyadiposestemcelltransplantation
‡A
Slowed progression in models of Huntington disease by adipose stem cell transplantation
‡9
1
|
|
919
|
|
|
‡a
solublemediatorsfromhumanneuralstemcellsplayacriticalroleinsuppressionoftcellactivationandproliferation
‡A
Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation.
‡9
1
|
|
919
|
|
|
‡a
sonographicfindingsassociatedwithstenosisprogressionandvascularcomplicationsinmoyamoyadisease
‡A
Sonographic findings associated with stenosis progression and vascular complications in moyamoya disease.
‡9
1
|
|
919
|
|
|
‡a
stemcellbasedcelltherapyforhuntingtondiseaseareview
‡A
Stem cell-based cell therapy for Huntington disease: a review
‡9
1
|
|
919
|
|
|
‡a
stemcellstransplantationandhuntingtonsdisease
‡A
Stem Cells Transplantation and Huntington's Disease
‡9
1
|
|
919
|
|
|
‡a
strokemimickingencephalopathyasaninitialmanifestationofdiffuselargebcelllymphoma
‡A
Stroke mimicking encephalopathy as an initial manifestation of diffuse large B-cell lymphoma
‡9
1
|
|
919
|
|
|
‡a
successfultreatmentofrefractorydyskinesiasecondarytoantinmethyl500aspartatereceptorencephalitiswithelectroconvulsivetherapy
‡A
Successful Treatment of Refractory Dyskinesia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Electroconvulsive Therapy
‡9
1
|
|
919
|
|
|
‡a
sunginsengprotectsendothelialprogenitorcellsfromsenescenceassociatedapoptosis
‡A
Sun ginseng protects endothelial progenitor cells from senescence associated apoptosis
‡9
1
|
|
919
|
|
|
‡a
survivalgainwithreoprtforrecurredhighgradegliomasdependsuponriskgroups
‡A
Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups
‡9
1
|
|
919
|
|
|
‡a
switchingbetweenphenytoingenericsinpatientswithepilepsymayleadtoincreasedriskofbreakthroughseizurechartanalysisandpracticerecommendations
‡A
Switching between phenytoin generics in patients with epilepsy may lead to increased risk of breakthrough seizure: chart analysis and practice recommendations
‡9
1
|
|
919
|
|
|
‡a
systemictransplantationofhumanadiposestemcellsattenuatedcerebralinflammationanddegenerationinahemorrhagicstrokemodel
‡A
Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model.
‡9
1
|
|
919
|
|
|
‡a
100ablinhibitornilotinibasapotentialtherapeuticagentforchroniccerebellarataxia
‡A
The c-Abl inhibitor, nilotinib, as a potential therapeutic agent for chronic cerebellar ataxia
‡9
1
|
|
919
|
|
|
‡a
complexityofdiagnosingposturalorthostatictachycardiasyndromeinfluenceofthediurnalvariability
‡A
The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability.
‡9
1
|
|
919
|
|
|
‡a
effectofdimlightatnightoncerebralhemodynamicoscillationsduringsleepanearinfraredspectroscopystudy
‡A
The effect of dim light at night on cerebral hemodynamic oscillations during sleep: A near-infrared spectroscopy study
‡9
1
|
|
919
|
|
|
‡a
effectofparoxetineonthereductionofmigrainefrequencyisindependentofitsanxiolyticeffect
‡A
The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect
‡9
1
|
|
919
|
|
|
‡a
efficacyofcombinedestrogenandbuspironetreatmentinolivopontocerebellaratrophy
‡A
The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy
‡9
1
|
|
919
|
|
|
‡a
hlaa2402cw0102haplotypeisassociatedwithlamotrigineinducedmaculopapulareruptioninthekoreanpopulation
‡A
The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population
‡9
1
|
|
919
|
|
|
‡a
longtermefficacyandsafetyoflevetiracetaminatertiaryepilepsycentre
‡A
The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre
‡9
1
|
|
919
|
|
|
‡a
3yearretentionratesoflevetiracetamtopiramateandoxcarbazepinearetrospectivehospitalbasedstudy
‡A
Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study
‡9
1
|
|
919
|
|
|
‡a
tocilizumabinautoimmuneencephalitisrefractorytorituximabaninstitutionalcohortstudy
‡A
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study.
‡9
1
|
|
919
|
|
|
‡a
tocilizumabtreatmentfornewonsetrefractorystatusepilepticus
‡A
Tocilizumab treatment for new-onset refractory status epilepticus
‡9
1
|
|
919
|
|
|
‡a
tolerabilityoflacosamiderapiddosetitrationarandomizedmulticenterprospectiveopenlabelstudy
‡A
Tolerability of lacosamide rapid dose titration: A randomized, multicenter, prospective, open-label study
‡9
1
|
|
919
|
|
|
‡a
toleratednitritetherapyinexperimentalintracerebralhemorrhagerationaleofnitritetherapyinabroadrangeofhyperacutestrokes
‡A
Tolerated nitrite therapy in experimental intracerebral hemorrhage: Rationale of nitrite therapy in a broad range of hyperacute strokes.
‡9
1
|
|
919
|
|
|
‡a
vgkccomplexlgi1antibodyencephalitisclinicalmanifestationsandresponsetoimmunotherapy
‡A
VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.
‡9
1
|
|
919
|
|
|
‡a
treatmentstrategiesforautoimmuneencephalitis
‡A
Treatment strategies for autoimmune encephalitis
‡9
1
|
|
919
|
|
|
‡a
topiramateincreasestheriskofvalproicacidinducedencephalopathy
‡A
Topiramate increases the risk of valproic acid-induced encephalopathy
‡9
1
|
|
919
|
|
|
‡a
transplantationofhumanneuralstemcellsprotectagainstischemiainapreventivemodeviahypoxiainduciblefactor1 Alpha stabilizationinthehostbrain
‡A
Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1 Alpha stabilization in the host brain
‡9
1
|
|
919
|
|
|
‡a
transplantationofpatientderivedadiposestemcellsinyac128huntingtonsdiseasetransgenicmice
‡A
Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice
‡9
1
|
|
919
|
|
|
‡a
uniquebehavioralcharacteristicsandmicrornasignaturesinadrugresistantepilepsymodel
‡A
Unique behavioral characteristics and microRNA signatures in a drug resistant epilepsy model
‡9
1
|
|
919
|
|
|
‡a
whitematterhyperintensitiesandcognitivedysfunctioninalzheimerdisease
‡A
White matter hyperintensities and cognitive dysfunction in Alzheimer disease
‡9
1
|
|
919
|
|
|
‡a
underexpressionofhoxa11isassociatedwithtreatmentresistanceandpoorprognosisinglioblastoma
‡A
Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma
‡9
1
|
|
919
|
|
|
‡a
unfavorablesurgicaloutcomesinpartialepilepsywithsecondarybilateralsynchronyintracranialelectroencephalographystudy
‡A
Unfavorable surgical outcomes in partial epilepsy with secondary bilateral synchrony: Intracranial electroencephalography study.
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2016
‡9
3
|
|
996
|
|
|
‡2
ISNI|0000000464778786
|
|
996
|
|
|
‡2
NII|DA02162455
|
|
996
|
|
|
‡2
ISNI|0000000505786994
|
|
996
|
|
|
‡2
ISNI|0000000468278551
|
|
996
|
|
|
‡2
ISNI|0000000464633018
|
|
996
|
|
|
‡2
BLBNB|000234462
|
|
996
|
|
|
‡2
ISNI|0000000492993387
|
|
996
|
|
|
‡2
ISNI|0000000475141772
|
|
996
|
|
|
‡2
LC|no2021105386
|
|
996
|
|
|
‡2
ISNI|0000000464867594
|
|
996
|
|
|
‡2
ISNI|0000000491604079
|
|
996
|
|
|
‡2
ISNI|000000002340202X
|
|
996
|
|
|
‡2
RERO|A023562764
|
|
996
|
|
|
‡2
ISNI|0000000049776265
|
|
996
|
|
|
‡2
ISNI|0000000493207296
|
|
996
|
|
|
‡2
ISNI|0000000477338413
|
|
996
|
|
|
‡2
NUKAT|n 2013156442
|
|
996
|
|
|
‡2
ISNI|0000000464850944
|
|
996
|
|
|
‡2
SUDOC|279627319
|
|
996
|
|
|
‡2
ISNI|0000000493976503
|
|
996
|
|
|
‡2
ISNI|0000000475916427
|
|
996
|
|
|
‡2
ISNI|000000047518393X
|
|
996
|
|
|
‡2
LC|no2022053665
|
|
996
|
|
|
‡2
ISNI|000000047769969X
|
|
996
|
|
|
‡2
LC|n 2021037103
|
|
996
|
|
|
‡2
ISNI|0000000494005768
|
|
996
|
|
|
‡2
ISNI|0000000050062032
|
|
996
|
|
|
‡2
DNB|1139716344
|
|
996
|
|
|
‡2
LC|n 82074716
|
|
996
|
|
|
‡2
ISNI|0000000480110807
|
|
996
|
|
|
‡2
RERO|A024048215
|
|
996
|
|
|
‡2
NLA|000035297485
|
|
996
|
|
|
‡2
ISNI|0000000475208957
|
|
996
|
|
|
‡2
DNB|1245460897
|
|
996
|
|
|
‡2
ISNI|0000000465146780
|
|
996
|
|
|
‡2
ISNI|0000000051897541
|
|
996
|
|
|
‡2
ISNI|0000000473711209
|
|
996
|
|
|
‡2
ISNI|000000051687691X
|
|
996
|
|
|
‡2
ISNI|0000000464412848
|
|
996
|
|
|
‡2
ISNI|0000000483498878
|
|
996
|
|
|
‡2
DNB|119198061
|
|
996
|
|
|
‡2
ISNI|0000000467023098
|
|
996
|
|
|
‡2
ISNI|0000000477496075
|
|
996
|
|
|
‡2
ISNI|000000046834554X
|
|
996
|
|
|
‡2
ISNI|0000000464905132
|
|
996
|
|
|
‡2
ISNI|0000000460689938
|
|
996
|
|
|
‡2
ISNI|000000047395071X
|
|
996
|
|
|
‡2
ISNI|0000000493981919
|
|
996
|
|
|
‡2
ISNI|0000000467722534
|
|
996
|
|
|
‡2
ISNI|0000000505381444
|
|
996
|
|
|
‡2
ISNI|0000000503713396
|
|
996
|
|
|
‡2
ISNI|0000000513667282
|
|
996
|
|
|
‡2
BIBSYS|99051271
|
|
996
|
|
|
‡2
ISNI|0000000075300551
|
|
996
|
|
|
‡2
ISNI|0000000477601402
|
|
996
|
|
|
‡2
ISNI|0000000505924306
|
|
996
|
|
|
‡2
ISNI|0000000477257349
|
|
996
|
|
|
‡2
ISNI|0000000395841162
|
|
996
|
|
|
‡2
ISNI|0000000492353873
|
|
996
|
|
|
‡2
ISNI|000000050521913X
|
|
996
|
|
|
‡2
ISNI|0000000516715008
|
|
996
|
|
|
‡2
ISNI|0000000464412530
|
|
996
|
|
|
‡2
BNF|16572170
|
|
996
|
|
|
‡2
NII|DA06781765
|
|
996
|
|
|
‡2
ISNI|0000000512322012
|
|
996
|
|
|
‡2
NSK|000346984
|
|
996
|
|
|
‡2
ISNI|000000048026008X
|
|
996
|
|
|
‡2
ISNI|0000000505799680
|
|
996
|
|
|
‡2
BIBSYS|1006852
|
|
996
|
|
|
‡2
ISNI|0000000474016021
|
|
996
|
|
|
‡2
LC|n 2001119603
|
|
996
|
|
|
‡2
LC|n 87820889
|
|
996
|
|
|
‡2
ISNI|0000000465018914
|
|
996
|
|
|
‡2
ISNI|0000000463341144
|
|
996
|
|
|
‡2
DNB|1038080762
|
|
996
|
|
|
‡2
ISNI|0000000491653022
|
|
996
|
|
|
‡2
ISNI|0000000476792024
|
|
996
|
|
|
‡2
ISNI|0000000475980218
|
|
996
|
|
|
‡2
LC|nr2007005250
|
|
996
|
|
|
‡2
ISNI|0000000479235944
|
|
996
|
|
|
‡2
ISNI|0000000513667194
|
|
996
|
|
|
‡2
ISNI|0000000508115408
|
|
996
|
|
|
‡2
ISNI|0000000483872030
|
|
996
|
|
|
‡2
ISNI|0000000464779244
|
|
996
|
|
|
‡2
ISNI|0000000491804310
|
|
996
|
|
|
‡2
ISNI|0000000078739551
|
|
996
|
|
|
‡2
BIBSYS|4067111
|
|
996
|
|
|
‡2
NUKAT|n 98001111
|
|
996
|
|
|
‡2
ISNI|0000000475527907
|
|
996
|
|
|
‡2
LC|n 91044060
|
|
996
|
|
|
‡2
SUDOC|187445818
|
|
996
|
|
|
‡2
ISNI|0000000491820564
|
|
996
|
|
|
‡2
ISNI|000000050512478X
|
|
996
|
|
|
‡2
ISNI|0000000479180402
|
|
996
|
|
|
‡2
ISNI|000000048020239X
|
|
996
|
|
|
‡2
ISNI|0000000024229644
|
|
996
|
|
|
‡2
ISNI|0000000082146492
|
|
996
|
|
|
‡2
ISNI|0000000466956750
|
|
996
|
|
|
‡2
LC|nr 98023423
|
|
996
|
|
|
‡2
ISNI|0000000052725012
|
|
996
|
|
|
‡2
LC|n 78059809
|
|
996
|
|
|
‡2
ISNI|0000000468548435
|
|
996
|
|
|
‡2
LC|n 2019024863
|
|
996
|
|
|
‡2
NTA|110256859
|
|
996
|
|
|
‡2
ISNI|0000000483893763
|
|
996
|
|
|
‡2
ISNI|0000000459350064
|
|
996
|
|
|
‡2
DNB|1166192091
|
|
996
|
|
|
‡2
LC|n 84133932
|
|
996
|
|
|
‡2
ISNI|0000000465033989
|
|
996
|
|
|
‡2
ISNI|0000000045677825
|
|
996
|
|
|
‡2
ISNI|000000047248880X
|
|
996
|
|
|
‡2
ISNI|0000000463656226
|
|
996
|
|
|
‡2
ISNI|000000047907428X
|
|
996
|
|
|
‡2
ISNI|0000000050584105
|
|
996
|
|
|
‡2
ISNI|0000000480086747
|
|
996
|
|
|
‡2
ISNI|0000000493963702
|
|
996
|
|
|
‡2
LC|nr 95038645
|
|
996
|
|
|
‡2
ISNI|000000047248901X
|
|
996
|
|
|
‡2
ISNI|0000000436939554
|
|
996
|
|
|
‡2
ISNI|0000000505299504
|
|
996
|
|
|
‡2
ISNI|0000000492527941
|
|
996
|
|
|
‡2
NLB|18593178
|
|
996
|
|
|
‡2
NII|DA12031089
|
|
996
|
|
|
‡2
ISNI|0000000491823562
|
|
996
|
|
|
‡2
PLWABN|9810591515705606
|
|
996
|
|
|
‡2
LC|no2010180093
|
|
996
|
|
|
‡2
ISNI|0000000373904003
|
|
996
|
|
|
‡2
ISNI|0000000513635491
|
|
996
|
|
|
‡2
ISNI|0000000473401921
|
|
996
|
|
|
‡2
ISNI|0000000512737867
|
|
996
|
|
|
‡2
ISNI|0000000476702383
|
|
996
|
|
|
‡2
NSK|000465796
|
|
996
|
|
|
‡2
ISNI|0000000483575802
|
|
996
|
|
|
‡2
ISNI|0000000476729033
|
|
996
|
|
|
‡2
SUDOC|258327006
|
|
996
|
|
|
‡2
ISNI|000000047783525X
|
|
996
|
|
|
‡2
ISNI|0000000050111391
|
|
996
|
|
|
‡2
ISNI|0000000463240714
|
|
996
|
|
|
‡2
ISNI|0000000512297646
|
|
996
|
|
|
‡2
ISNI|0000000473855843
|
|
996
|
|
|
‡2
J9U|987007438426405171
|
|
996
|
|
|
‡2
ISNI|0000000480177577
|
|
996
|
|
|
‡2
ISNI|0000000023438057
|
|
996
|
|
|
‡2
ISNI|0000000463402082
|
|
996
|
|
|
‡2
NTA|303073527
|
|
996
|
|
|
‡2
ISNI|0000000491964883
|
|
996
|
|
|
‡2
LC|no2012045526
|
|
996
|
|
|
‡2
ISNI|0000000467784751
|
|
996
|
|
|
‡2
LC|nr 96025138
|
|
996
|
|
|
‡2
ISNI|0000000464783251
|
|
996
|
|
|
‡2
ISNI|0000000505929991
|
|
996
|
|
|
‡2
LC|n 50039574
|
|
996
|
|
|
‡2
ISNI|0000000464664762
|
|
996
|
|
|
‡2
ISNI|0000000513635571
|
|
996
|
|
|
‡2
ISNI|0000000468468398
|
|
996
|
|
|
‡2
ISNI|0000000492354139
|
|
996
|
|
|
‡2
ISNI|0000000124900810
|
|
996
|
|
|
‡2
BIBSYS|90330184
|
|
996
|
|
|
‡2
LC|nr 93024343
|
|
996
|
|
|
‡2
ISNI|000000049223839X
|
|
996
|
|
|
‡2
CAOONL|ncf11448852
|
|
996
|
|
|
‡2
ISNI|0000000468465680
|
|
996
|
|
|
‡2
ISNI|0000000493979309
|
|
996
|
|
|
‡2
DNB|1169097537
|
|
996
|
|
|
‡2
LC|n 82254067
|
|
996
|
|
|
‡2
ISNI|0000000493979923
|
|
996
|
|
|
‡2
NDL|01146168
|
|
996
|
|
|
‡2
ISNI|0000000407756425
|
|
996
|
|
|
‡2
ISNI|0000000468465314
|
|
996
|
|
|
‡2
LC|n 98081758
|
|
996
|
|
|
‡2
DNB|1159025819
|
|
996
|
|
|
‡2
ISNI|0000000509029026
|
|
996
|
|
|
‡2
DNB|1074172736
|
|
996
|
|
|
‡2
ISNI|0000000459350048
|
|
996
|
|
|
‡2
ISNI|0000000479238416
|
|
996
|
|
|
‡2
ISNI|0000000493069727
|
|
996
|
|
|
‡2
ISNI|0000000493961336
|
|
996
|
|
|
‡2
ISNI|0000000115857136
|
|
996
|
|
|
‡2
ISNI|0000000493901915
|
|
996
|
|
|
‡2
LC|n 99804100
|
|
996
|
|
|
‡2
ISNI|0000000472489052
|
|
996
|
|
|
‡2
DNB|1051410568
|
|
996
|
|
|
‡2
LC|n 2024021886
|
|
996
|
|
|
‡2
ISNI|0000000475034707
|
|
996
|
|
|
‡2
ISNI|0000000505498343
|
|
996
|
|
|
‡2
ISNI|0000000461118803
|
|
996
|
|
|
‡2
ISNI|0000000460129877
|
|
996
|
|
|
‡2
ISNI|0000000464412872
|
|
996
|
|
|
‡2
RERO|A006202569
|
|
996
|
|
|
‡2
ISNI|0000000465139302
|
|
996
|
|
|
‡2
ISNI|000000046476240X
|
|
996
|
|
|
‡2
LC|nr 98027624
|
|
996
|
|
|
‡2
LC|n 2006184129
|
|
996
|
|
|
‡2
BNF|13626499
|
|
996
|
|
|
‡2
NTA|344683915
|
|
996
|
|
|
‡2
ISNI|0000000505195262
|
|
996
|
|
|
‡2
ISNI|0000000503599933
|
|
996
|
|
|
‡2
ISNI|000000050354596X
|
|
996
|
|
|
‡2
ISNI|0000000464369202
|
|
996
|
|
|
‡2
ISNI|0000000480871139
|
|
996
|
|
|
‡2
ISNI|000000046479011X
|
|
996
|
|
|
‡2
LC|n 89671798
|
|
996
|
|
|
‡2
ISNI|0000000483582615
|
|
996
|
|
|
‡2
ISNI|000000050531900X
|
|
996
|
|
|
‡2
ISNI|0000000366058785
|
|
996
|
|
|
‡2
ISNI|0000000468300149
|
|
996
|
|
|
‡2
ISNI|0000000431061199
|
|
996
|
|
|
‡2
ISNI|0000000463276346
|
|
996
|
|
|
‡2
ISNI|0000000483560053
|
|
996
|
|
|
‡2
ISNI|0000000467655562
|
|
996
|
|
|
‡2
LC|no2021105274
|
|
996
|
|
|
‡2
ISNI|000000046340212X
|
|
996
|
|
|
‡2
LC|n 2015031085
|
|
996
|
|
|
‡2
ISNI|0000000464756413
|
|
996
|
|
|
‡2
ISNI|0000000512528950
|
|
996
|
|
|
‡2
ISNI|0000000067740346
|
|
996
|
|
|
‡2
ISNI|0000000480202525
|
|
996
|
|
|
‡2
ISNI|0000000465098803
|
|
996
|
|
|
‡2
ISNI|0000000039042495
|
|
996
|
|
|
‡2
ISNI|0000000474007969
|
|
996
|
|
|
‡2
SUDOC|145227103
|
|
996
|
|
|
‡2
CAOONL|ncf10254555
|
|
996
|
|
|
‡2
ISNI|0000000475965472
|
|
996
|
|
|
‡2
BIBSYS|90519814
|
|
996
|
|
|
‡2
J9U|987007286180305171
|
|
996
|
|
|
‡2
NII|DA14216777
|
|
996
|
|
|
‡2
ISNI|0000000464929636
|
|
996
|
|
|
‡2
ISNI|000000046441259X
|
|
996
|
|
|
‡2
DNB|130272558
|
|
996
|
|
|
‡2
BNF|15746978
|
|
996
|
|
|
‡2
SUDOC|252897102
|
|
996
|
|
|
‡2
LIH|LNB:C_b_1K;=BH
|
|
996
|
|
|
‡2
ISNI|000000049398209X
|
|
996
|
|
|
‡2
DNB|1089445970
|
|
996
|
|
|
‡2
ISNI|0000000493981353
|
|
996
|
|
|
‡2
DNB|1154617645
|
|
996
|
|
|
‡2
LC|n 99265616
|
|
996
|
|
|
‡2
ISNI|0000000464845336
|
|
996
|
|
|
‡2
ISNI|0000000505945035
|
|
996
|
|
|
‡2
ISNI|0000000493980465
|
|
996
|
|
|
‡2
ISNI|000000048349771X
|
|
996
|
|
|
‡2
BIBSYS|90234865
|
|
996
|
|
|
‡2
ISNI|0000000477319335
|
|
996
|
|
|
‡2
LC|no2016123233
|
|
996
|
|
|
‡2
ISNI|0000000491935046
|
|
996
|
|
|
‡2
ISNI|0000000468166197
|
|
996
|
|
|
‡2
RERO|A003507437
|
|
996
|
|
|
‡2
ISNI|0000000473921732
|
|
996
|
|
|
‡2
ISNI|0000000493245604
|
|
996
|
|
|
‡2
LC|no 00084370
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
